Generics in Brazil - Market Summary, Competitive Analysis and Forecast to 2025
Generics in Brazil - Market @Summary, Competitive Analysis and Forecast to 2025
SUMMARY
Generics in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Brazilian generics market had total revenues of $5.3bn in 2020, representing a compound annual growth rate (CAGR) of 9.9% between 2016 and 2020.
- Market consumption volume increased with a CAGR of 3.2% between 2016 and 2020, to reach a total of 36.1 % in 2020.
- Growth in the Brazilian market has been driven by a bourgeoning middle class and an aging population, who are more likely to have chronic diseases.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Brazil
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Brazil
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil generics market with five year forecasts by both value and volume
- What was the size of the Brazil generics market by value in 2020?
- What will be the size of the Brazil generics market in 2025?
- What factors are affecting the strength of competition in the Brazil generics market?
- How has the market performed over the last five years?
- Who are the top competitiors in Brazil's generics market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. EMS SA
8.3. Ache Laboratorios Farmaceuticos SA
8.4. Eurofarma Laboratorios SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?
8 COMPANY PROFILES
8.1. Sanofi SA
8.2. EMS SA
8.3. Ache Laboratorios Farmaceuticos SA
8.4. Eurofarma Laboratorios SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Brazil generics market value: $ million, 2016-20
Table 2: Brazil generics market volume: %, 2016-20
Table 3: Brazil generics market geography segmentation: $ million, 2020
Table 4: Brazil generics market value forecast: $ million, 2020-25
Table 5: Brazil generics market volume forecast: %, 2020-25
Table 6: Sanofi SA: key facts
Table 7: Sanofi SA: Annual Financial Ratios
Table 8: Sanofi SA: Key Employees
Table 9: Sanofi SA: Key Employees Continued
Table 10: EMS SA: key facts
Table 11: EMS SA: Key Employees
Table 12: Ache Laboratorios Farmaceuticos SA: key facts
Table 13: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 14: Eurofarma Laboratorios SA: key facts
Table 15: Eurofarma Laboratorios SA: Key Employees
Table 16: Brazil size of population (million), 2016-20
Table 17: Brazil gdp (constant 2005 prices, $ billion), 2016-20
Table 18: Brazil gdp (current prices, $ billion), 2016-20
Table 19: Brazil inflation, 2016-20
Table 20: Brazil consumer price index (absolute), 2016-20
Table 21: Brazil exchange rate, 2016-20
Table 1: Brazil generics market value: $ million, 2016-20
Table 2: Brazil generics market volume: %, 2016-20
Table 3: Brazil generics market geography segmentation: $ million, 2020
Table 4: Brazil generics market value forecast: $ million, 2020-25
Table 5: Brazil generics market volume forecast: %, 2020-25
Table 6: Sanofi SA: key facts
Table 7: Sanofi SA: Annual Financial Ratios
Table 8: Sanofi SA: Key Employees
Table 9: Sanofi SA: Key Employees Continued
Table 10: EMS SA: key facts
Table 11: EMS SA: Key Employees
Table 12: Ache Laboratorios Farmaceuticos SA: key facts
Table 13: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 14: Eurofarma Laboratorios SA: key facts
Table 15: Eurofarma Laboratorios SA: Key Employees
Table 16: Brazil size of population (million), 2016-20
Table 17: Brazil gdp (constant 2005 prices, $ billion), 2016-20
Table 18: Brazil gdp (current prices, $ billion), 2016-20
Table 19: Brazil inflation, 2016-20
Table 20: Brazil consumer price index (absolute), 2016-20
Table 21: Brazil exchange rate, 2016-20
LIST OF FIGURES
Figure 1: Brazil generics market value: $ million, 2016-20
Figure 2: Brazil generics market volume: %, 2016-20
Figure 3: Brazil generics market geography segmentation: % share, by value, 2020
Figure 4: Brazil generics market value forecast: $ million, 2020-25
Figure 5: Brazil generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in Brazil, 2020
Figure 7: Drivers of buyer power in the generics market in Brazil, 2020
Figure 8: Drivers of supplier power in the generics market in Brazil, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in Brazil, 2020
Figure 11: Drivers of degree of rivalry in the generics market in Brazil, 2020
Figure 1: Brazil generics market value: $ million, 2016-20
Figure 2: Brazil generics market volume: %, 2016-20
Figure 3: Brazil generics market geography segmentation: % share, by value, 2020
Figure 4: Brazil generics market value forecast: $ million, 2020-25
Figure 5: Brazil generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in Brazil, 2020
Figure 7: Drivers of buyer power in the generics market in Brazil, 2020
Figure 8: Drivers of supplier power in the generics market in Brazil, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in Brazil, 2020
Figure 11: Drivers of degree of rivalry in the generics market in Brazil, 2020
